Axelrod and Wurtman, in 1960, demonstrated that the decline in adrenal phenylethanolarnine-N-methyltransferase (PNMT) enzymatic activity following hypophysectomy in rats could be reversed by administration of the synthetic glucocorticoid, dexamethasone. It was more than two decades later those glucocorticoids were shown to increase steady-state levels of PNMT mRNA, primarily by enhancing the rate of PNMT gene transcription. Neurally mediated regulation of PNMT expression in adrenal chromaffin cells occurs predominantly through the influence of cholinergic stimuli on nicotinic and muscarinic receptors. A single neurotransmitter, acetylcholine, is capable of acting through two separate intracellular signaling pathways to stimulate transcription of the PNMT gene. Although the importance of cell-specific determinants has been recognized in a number of systems, only recently have it has been begun to characterize those sequences responsible for the highly restricted expression of PNMT. Not surprisingly, the PNMT gene likewise possesses information that directs the site of its expression. Transient transfections of upstream PNMT promoter regions were conducted utilizing an array of pheochromocytoma, neuroblastoma, glioma, fibroblast, and myoblast continuous cell lines. Deletion of the most distal element produces enhancement of reporter gene expression in nonadrenergic, nonchromaffin cell types. The PNMT mid and proximal cell-specific regions each share approximately 70% sequence similarity with a derived consensus sequence for neural specific silencers. Deletion of the regions of the PNMT promoter between -647 and -572 bp and between -572 and -537 bp produces enhancement of reporter gene constructs transfected into nonneuronal cell types, for example, C6 glioma and L6 myoblast lines. This chapter has demonstrated that the major influences establishing the physiological level of PNMT expression can be classified as hormonal, neural, and cell-specific in nature.
Read full abstract